These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 5537653)
41. [Geriatric experiences with Aolep]. Jansen W Munch Med Wochenschr; 1966 Sep; 108(39):1926-8. PubMed ID: 6014871 [No Abstract] [Full Text] [Related]
42. [Experience with the new tranquilizing agent Wy 4036 (lorazepam) in the specialties psychiatric neurology and internal medicine]. Leube H; Höffkes H Arzneimittelforschung; 1971 Jul; 21(7):1098-102. PubMed ID: 5109550 [No Abstract] [Full Text] [Related]
44. [Possibilities of therapeutic control of exhaustion states and psychoneurotic disorders]. Michalová C Psychiatr Neurol Med Psychol (Leipz); 1965 Jun; 17(6):225-32. PubMed ID: 4378600 [No Abstract] [Full Text] [Related]
45. [Acute neurotic decompensation]. Pelicier Y Presse Med (1893); 1970 Sep; 78(39):1709-11. PubMed ID: 5460384 [No Abstract] [Full Text] [Related]
46. [Importance of motor resonance in psychoneuroses]. Brzezicki E Przegl Lek; 1971 Nov; 28(11):721-4. PubMed ID: 4944329 [No Abstract] [Full Text] [Related]
47. [Evaluation of a new benzodiazepine preparation, S-804, for the treatment of psychoneurotic and psychosomatic disorders by double-blind cross-over test]. Tanaka H; Takayama I; Ookubo N; Yoshimuta S; Kono Y Saishin Igaku; 1970 May; 25(5):1128-36. PubMed ID: 4912179 [No Abstract] [Full Text] [Related]
48. Clinical pharmacology of psychotropic drugs. Ban TA Appl Ther; 1967 Apr; 9(4):366-71. PubMed ID: 6039139 [No Abstract] [Full Text] [Related]
49. [Psychopharmacologic therapy of neuroses. The problem of personality and its influence on the therapeutic results]. Barcia D; Martínez Carrillo JA; Morales JM; Agüero A Actas Luso Esp Neurol Psiquiatr; 1970 Jan; 29(1):17-38. PubMed ID: 5482847 [No Abstract] [Full Text] [Related]
50. Trioxazine; its history and therapeutic use. Kósa L Ther Hung; 1973; 21(2):85-7. PubMed ID: 4600840 [No Abstract] [Full Text] [Related]
51. [On the position of butyrophenone derivative Triperidol in psychiatric treatment]. Lange E; Scholz V Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(6):202-7. PubMed ID: 5731875 [No Abstract] [Full Text] [Related]
53. [Results of a clinical and ambulatory comparative study involving two tranquilizing drug compounds]. Boysen KH Wien Med Wochenschr; 1974 Jul; 124(30):475-7. PubMed ID: 4428781 [No Abstract] [Full Text] [Related]
54. [Asthma as a psychosomatic disease and its treatment with tranquilizing agents]. Cornia G; Cornia C; Lorenzini R; Giammarruto R; Siani V; Mariotta S; Pasqua F Minerva Med; 1977 Jan; 68(1):29-32. PubMed ID: 834381 [TBL] [Abstract][Full Text] [Related]
55. [The use of psychopharmacologic agents in certain indicated groups]. Scharfetter C Med Klin; 1967 Jun; 62(22):861-3. PubMed ID: 4385893 [No Abstract] [Full Text] [Related]
57. [Trial of a new anxiolytic agent (RO-4556) in cardiologic practice]. Roux M; Herne N; Veron L; Kerdelhue H; Trigano Mars Med; 1970; 107(9):683-7. PubMed ID: 5470846 [No Abstract] [Full Text] [Related]
58. Pilot evaluation of flexin as a tranquilizing agent in chronic mental disorders. WILKENS B; MALITZ S; GLUSMAN M; HOCH PH Psychiatr Q; 1958 Oct; 32(4):691-707. PubMed ID: 13634266 [No Abstract] [Full Text] [Related]
59. Further investigation of factors affecting outcome in a doctor's choice treatment setting. Tupin JP; Overall JE Dis Nerv Syst; 1970 Oct; 31(10):684-94. PubMed ID: 5482918 [No Abstract] [Full Text] [Related]
60. [Neuroses and their related diseases and tranquilizing agents]. Suwa N Naika; 1967 Jun; 19(6):1271-5. PubMed ID: 6079610 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]